Similar antibody concentrations in Filipino infants at age 9 months, after 1 or 3 doses of an adjuvanted, 11-valent pneumococcal diphtheria/tetanus- conjugated vaccine: A randomized controlled trial

Journal of Infectious Diseases

Volumn 189, Issue 11, 2004, Pages 2077-2084

  Lucero, Marilla G ^a,d   Puumalainen, Taneli ^b   Ugpo, Juanita M ^a   Williams, Gail ^c   Käyhty, Helena ^b   Nohynek, Hanna ^b  

^a RESEARCH INSTITUTE FOR TROPICAL MEDICINE   (Philippines)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d Department of Dermatology   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA TETANUS VACCINE;

ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG CONJUGATION; FEMALE; FILIPINO; HUMAN; IMMUNOGENICITY; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEROTYPE; STREPTOCOCCUS INFECTION; TREATMENT OUTCOME; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ALUMINUM HYDROXIDE; ANTIBODIES, VIRAL; DIPHTHERIA TOXOID; HUMANS; IMMUNOENZYME TECHNIQUES; INFANT; INJECTIONS, INTRAMUSCULAR; PHILIPPINES; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; TETANUS TOXOID; VACCINES, CONJUGATE;

EID: 2542503296     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/420849     Document Type: Article

References (22)

1. Puumalainen T, Capeding R, Käyhty H, et al. Antibody response to an eleven valent diphtheria- and tetanus-conjugated pneumococcal conjugate vaccine in Filipino infants. Pediatr Infect Dis J 2002; 21:309-14.
2. Åhman H, Käyhty H, Tamminen P, Vuorela A, Malinoski F, Eskola J. Pentavalent pneumococcal oligosaccharide conjugate vaccine PncCRM is well-tolerated and able to induce an antibody response in infants. Pediatr Infect Dis J 1996; 15:134-9.
3. 197 conjugate vaccine in infants and toddlers. Pediatr Infect Dis J 1999; 18:757-63.
4. Obaro S, Adegbola R, Chang I, et al. Safety and immunogenicity of a nonavalent pneumococcal vaccine conjugated to CRM197 administered simultaneously but in a separate syringe with diphtheria, tetanus and pertussis vaccines in Gambian infants. Pediatr Infect Dis J 2000; 19:463-9.
5. Miernyk K, Parkinson A, Rudolph K, et al. Immunogenicity of a heptavalent pneumococcal conjugate vaccine in Apache and Navajo Indian, Alaska Native, and nonnative American children aged <2 years. Clin Infect Dis 2000; 31:34-41.
6. Bradely JS, Scheid WM. The challenge of penicillin-resistant Streptococcus pneumoniae meningitis: current antibiotic therapy in the 1990s. Clin Infect Dis 1997; 24(Suppl 2):S213-21.
7. Adam D. Global antibiotic resistance in Streptococcus pneumoniae. J Antimicrob Chemother 2002; 50(Suppl 1):1-5.
8. Black S, Shinefield H, Fireman B, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 2000; 19:187-95.
9. O'Brien KL, Moulton LH, Reid R, et al. Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomized trial. Lancet 2003; 362:355-61.
10. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001; 344:403-9.
11. Preventing pneumococcal disease among infants and young children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2000; 49:1-35.
12. Käyhty H, Åhman H, Rönnberg PR, Tillikainen R, Eskola J. Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children. J Infect Dis 1995; 172:1273-8.
13. Martinez JE, Romaro-Steiner S, Pilisvili T, et al. A flow cytometric opsonophagocytic assay for measurement of functional antibodies elicited after vaccination with the 23-valent pneumococcal polysaccharide vaccine. Clin Diagn Lab Immunol 1999; 6:581-6.
14. World Health Organization Expert Committee on Biological Standardization: Pneumococcal Conjugate Vaccines. Recommendations for production and quality control of pneumococcal conjugate vaccines. Available at: http://www.who.int/ biologicals/Guidelines/Vaccines.htm.
15. Peeters C, Tenenbergen-Meekes AM, Poolman JT, Beurret M, Zegers BJ, Rijers GT. Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccines. Infect Immun 1991; 59:3504-10.
16. Granoff D, Holmes S, Belshe R, Osterholm M, McHugh J, Anderson E. Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants. JAMA 1994; 272:1116-21.
17. Kurikka S, Kayhty H, Saarinen L, Ronnberg PR, Eskola J, Makela PH. Immunologic priming by one dose of Haemophilus influenzae type b conjugate vaccine in infancy. J Infect Dis 1995; 172:1268-72.
18. Åhman H, Käyhty H, Vuorela A, Leroy O, Eskola J. Dose dependency of antibody response in infants and children to pneumococcal polysaccharides conjugated to tetanus toxoid. Vaccine 1999; 17:2726-32.
19. Gratten M, Gratten H, Poli A, Carrad E, Raymer E, Koki G. Colonization of Haemophilus influenzae and Streptococcus pneumoniae in the upper respiratory tract of neonates in Papua New Guinea: primary acquisition, duration of carriage and relationship to carriage in mothers. Biol Neonate 1986; 50:114-20.
20. Nohynek H, Quiambao B, Gepanayao C, et al. Pneumococcal carriage in households with infants in the Philippines [abstract P5]. In: Program and abstracts of the 1st International Symposium on Pneumococci and Pneumococcal Diseases (Elsinore, Denmark). Washington, DC: American Society for Microbiology, 1998:3.
21. 197 in United States infants. Pediatrics 1998; 101:604-11.
22. Puumalainen T, Ekstrom N, Zeta-Capeding R, et al. Functional antibody responses to an 11-valent diphtheria and tetanus conjugated pneumococcal vaccine in Filipino infants. J Infect Dis 2003; 187:1704-8.